Hi Billy It's been a few sleeps since I put a post on, but I really couldn't be bothered wasting time just to have tossers crank you up as a ramper. I know you've done your due diligence as I've done and when Select moves into its commercialisation phase, red faces will be aplenty.
It's probably a fair comment to say the Frost factor has had more than a negative effect on the company and I think, on reflection, Select has realised as much and the Frost exit is noted.
Your post was spot on regarding Hep A, Hep E and Hep C. There is a facet of Select Vaccines that hasn't been factored in ie the delivery of Hepatitis antigens to the market. Select's intellectual property and outlicensing opportunities have huge potential and will not only benefit shareholders greatly but mankind in general.
When I first posted on Select many sleeps ago I didn't expect such a huge run so quick. Indeed its success led to its ultimate decline in market cap as the profit takers gorged. I however am in the same boat as you Billy. Not only have I refused to sell down a company I believe has huge potential, I have accumulated in anticipation of an early retirement.
Cheers The Cloud.
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
